ReviewItalian journal of pediatrics2026
Bridging eosinophilic esophagitis: healthcare transition from pediatric to adult patients.
Review in Italian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic esophagitis (EoE) is a chronic and progressive type 2 immune-mediated disease resulting in esophageal dysfunction. As with other chronic conditions, therapeutic continuity is crucial to ensure patient benefits, particularly during the transition of patients with EoE from pediatric to adult care. This investigation aimed to establish an algorithm to assist healthcare providers in optimizing the healthcare transition pathway through a multistep collaborative process that encompassed an initial analysis of the three principal currently available guidelines, the formulation of recommendations by a steering committee, and their validation through deliberation with a panel of 11 Italian EoE experts. Three essential criteria have been elucidated to define the healthcare transition pathway for pediatric patients with EoE to adulthood: readiness to transition, patient’s age, and disease control (from clinical, endoscopic, and histological perspectives). The algorithm incorporates the utilization of the STARx questionnaire as an efficacious instrument to assess patient’s readiness to transition, identifies the optimal age for this phase within the range of 14–18 years, and considers clinical, endoscopic, and histological control maintained for a minimum of 6 months. The availability of a standardized and well-defined pathway supporting healthcare professionals during the transition process of pediatric EoE patients to adulthood is associated with therapeutic continuity, enhancement of clinical outcomes, and prevention of long-term fibrostenotic complications, which may result in economic benefits for the Italian health system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.